colitis and glp-1 Ulcerative medications are a major focus for scientists right now., Here’s what’s happening: between 2024 and 2025, at least six studies have been published in respected journals GLP-1 Weight Loss with Ulcerative

After a two-year-long shortage, the FDA announced that Eli Lillys GLP-1 drug Mounjaro, and obesity version Zepbound, are back in stock.

Altimmune (NASDAQ:ALT) management used an appearance at the Goldman Sachs Global Healthcare Conference to outline the companys focus on pemvidutide, its lead metabolic and liver disease drug candidate, and to discuss the planned Phase 3 program in metabolic dysfunction-associated steatohepatitis, o

Hypromellose (Capsules): A plant-based, vegetarian capsule for easy consumption

Article in the comments #GLP1 #FoodTrends #ConsumerBehavior #CulturalListening #Innovation #Ozempic #TrendForecasting #FMCG #CPGMarketing #FutureOfFood | 12 comments on LinkedIn